Biotech ETFs Could Use Some Mergers & Acquisitions

The VanEck Vectors Biotech ETF (NYSEArca: BBH) is up nearly 8% year-to-date, but some industry observers are speculating that for large-cap biotechnology stocks to rally again, some more mergers and acquisitions activity will be required. BBH holds 25 stocks and tracks the MVIS US Listed Biotech 25...